0001567619-20-020818.txt : 20201209 0001567619-20-020818.hdr.sgml : 20201209 20201209175325 ACCESSION NUMBER: 0001567619-20-020818 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201207 FILED AS OF DATE: 20201209 DATE AS OF CHANGE: 20201209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anicetti Vincent R CENTRAL INDEX KEY: 0001733375 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36721 FILM NUMBER: 201378815 MAIL ADDRESS: STREET 1: COHERUS BIOSCIENCES, INC. STREET 2: 333 TWIN DOLPHIN DRIVE, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 4 1 doc1.xml FORM 4 X0306 4 2020-12-07 0 0001512762 Coherus BioSciences, Inc. CHRS 0001733375 Anicetti Vincent R COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 0 1 0 0 Chief Operating Officer Common Stock 2020-12-07 4 M 0 3000 12.37 A 35569 D Common Stock 2020-12-07 4 M 0 5791 12.70 A 41360 D Common Stock 2020-12-07 4 S 0 8791 18.4161 D 32569 D Stock Option (Right to Buy) 12.37 2020-12-07 4 M 0 3000 0.00 D 2029-01-11 Common Stock 3000 123000 D Stock Option (Right to Buy) 12.7 2020-12-07 4 M 0 5791 0.00 D 2027-08-06 Common Stock 5791 0 D Includes 31,250 restricted stock units. The transaction was executed in multiple trades in prices ranging from $18.30 to $18.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. All of the shares underlying this option are vested and exercisable as of the date hereof. /s/ Jean-Frederic Viret, as Attorney-in-Fact for Vincent R. Anicetti 2020-12-09